Tana Royal, NP
Nurse Practitioner · Raleigh, NCNPI 1740694231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 45 payments — averaging $25.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$152
- AbbVie$133
- Neurelis, Inc.$119
- Ipsen Biopharmaceuticals, Inc$114
- UCB, Inc.$105
- Collegium Pharmaceutical, Inc.$90
- plus $448 from 13 others
What the payments were for
- Food & beverage$1,161100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 2 | $152 |
| AbbVie | 7 | $133 |
| Neurelis, Inc. | 4 | $119 |
| Ipsen Biopharmaceuticals, Inc | 4 | $114 |
| UCB, Inc. | 4 | $105 |
| Collegium Pharmaceutical, Inc. | 4 | $90 |
| Tonix Medicines, Inc. | 1 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Lundbeck LLC | 2 | $49 |
| Merz Pharmaceuticals, LLC | 2 | $47 |
| Medtronic | 2 | $37 |
| Sumitomo Pharma America, Inc. | 3 | $35 |
| SK Life Science, Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Masimo Corporation | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Dynasplint Systems Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
How this compares
$1,161 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pravastatin Sodium | 13 | $185 |
| Donepezil Hcl | 14 | $177 |
| Quetiapine Fumarate | 17 | $142 |
| Lisinopril | 14 | $137 |
| Sertraline Hcl | 13 | $136 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Raleigh
- Sandrivette JohnsonRaleigh$573K
- Stephanie PascaleRaleigh$54K
- Victoria PoillucciRaleigh$23K
- Ayeshia WrightMocksville$145K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
- Deborah MayerChapel Hill$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.